Initiating Short-Acting Insulin in Primary Care

Indications for Short-Acting Insulin

The American Diabetes Association recommends adding prandial insulin when basal insulin has been titrated to acceptable fasting glucose levels but HbA1c remains above target after 3-6 months, particularly in patients with type 2 diabetes 3
The American College of Physicians suggests that postprandial glucose excursions exceeding 180 mg/dL despite adequate basal insulin dosing is an indication for short-acting insulin initiation 4
Patients presenting with marked hyperglycemia (glucose ≥300 mg/dL or HbA1c >10%) with symptoms should be initiated on short-acting insulin, according to the American Association of Clinical Endocrinologists 5

The Endocrine Society recommends that patients with type 1 diabetes require approximately 50% of total daily insulin as prandial coverage, with multiple daily injections combining basal and prandial insulin as the standard of care 6
The American Diabetes Association suggests that total daily insulin typically ranges from 0.4-1.0 units/kg/day, with half as prandial insulin, for patients with type 1 diabetes 6

The American College of Physicians recommends starting prandial insulin at the meal causing the largest postprandial glucose excursion, typically dinner, with an initial dose of 4 units of rapid-acting insulin or 10% of the basal insulin dose 3, 5
The Annals of Internal Medicine suggests that rapid-acting analogs are preferred over regular human insulin due to better postprandial glucose control and lower risk of late postprandial and nocturnal hypoglycemia 1, 3

The American Association of Clinical Endocrinologists recommends that patients must be thoroughly educated on recognizing symptoms of hypoglycemia and treatment protocols, with close monitoring for hypoglycemia as it is the primary adverse effect 1, 4
The American Diabetes Association suggests that daily self-monitoring of both fasting and postprandial glucose is mandatory during titration, with a target postprandial glucose <180 mg/dL 4

The Endocrine Society recommends that short-acting insulin must always be combined with basal insulin for 24-hour glucose control, and using rapid insulin alone without basal insulin is associated with suboptimal glycemic control 1, 7
The American College of Physicians suggests that rapid insulin should be avoided at bedtime to prevent nocturnal hypoglycemia 7

The American Association of Clinical Endocrinologists recommends considering adding a GLP-1 receptor agonist to basal insulin or switching to twice-daily premixed insulin as simpler alternatives before initiating prandial insulin in type 2 diabetes 3, 5
The Annals of Internal Medicine suggests that in low-resource settings, human regular insulin remains an acceptable alternative to rapid-acting analogs due to cost differences 8